Hsa-miR-31-3p expression is linked to progression-free survival in patients with KRAS wild-type metastatic colorectal cancer treated with anti-EGFR therapy. (Q54356802)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Hsa-miR-31-3p expression is linked to progression-free survival in patients with KRAS wild-type metastatic colorectal cancer treated with anti-EGFR therapy. |
scientific article |
Statements
Hsa-miR-31-3p expression is linked to progression-free survival in patients with KRAS wild-type metastatic colorectal cancer treated with anti-EGFR therapy. (English)
Gilles Manceau
Raphaële Thiébaut
François Liébaert
Karine Fontaine
Francis Rousseau
Bérengère Génin
Delphine Le Corre
Audrey Didelot
Marc Vincent
Benoist Chibaudel
Olivier Bouché
Bruno Landi
Frédéric Bibeau
Frédérique Penault-Llorca
Jean-Luc Van Laethem
Pieter Demetter
Sabine Tejpar
Simona Rossi
Neda Mosakhani
Pia Osterlund
Raija Ristamäki
Virinder Sarhadi
25 April 2014